See also this year's filing and all EDGAR filings for this company.
PDF Report 0001135906_2014_Epirus_Biopharmaceuticals_Inc.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
| warning | Similarly named company. Duplicate? | None | {'details': [{'other_company': 'Keryx Biopharmaceuticals INC', 'shared_tokens': {'biopharmaceuticals'}}]} |
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0001135906, Epirus Biopharmaceuticals Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 20,742,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 7,200,000 |
| 2 | PropertyPlantAndEquipmentNet | 2,363,000 |
| 3 | remainder_Assets | 1,801,000 |
| 4 | LiabilitiesCurrent | 14,892,000 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 7,523,000 |
| 9 | ResearchAndDevelopmentExpense | 33,964,000 |
| 10 | remainder_Expenses | 11,921,000 |
| 11 | remainder_Revenues | 14,731,000 |
| 12 | remainder_NetIncome | 60,000 |
| 13 | remainder_ComprehensiveNetIncome | -10,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 32,106,000 |
| 1 | Liabilities | 14,892,000 |
| 2 | Expenses | 53,408,000 |
| 3 | Revenues | 14,731,000 |
| 4 | StockholdersEquity | 17,214,000 |
| 5 | NetIncome | -38,617,000 |
| 6 | ComprehensiveNetIncome | -38,622,000 |
| 7 | BaseVar | 57,603,500 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | -0.0466 |
| 9 | EconomicCapitalRatio | 1.41 |
Edgar->Model Mapping
Feature Distribution
Change over Time
